Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer

膀胱切除术 医学 膀胱癌 危险系数 倾向得分匹配 比例危险模型 泌尿科 内科学 累积发病率 回顾性队列研究 置信区间 入射(几何) 队列 癌症 肿瘤科 外科 物理 光学
作者
Pietro Scilipoti,Mattia Longoni,Mario de Angelis,Paolo Zaurito,Aleksander Ślusarczyk,Francesco Soria,Benjamin Pradere,Wojciech Krajewski,David D’Andrea,Andrea Mari,Francesco Del Giudice,Renate Pichler,José Daniel Subiela,Gautier Marcq,Andrea Gallioli,Luca Afferi,Riccardo Mastroianni,Giuseppe Simone,Simone Albisinni,Laura S. Mertens,Ekaterina Laukhtina,Katharina Oberneder,José Luis Rodríguez Elena,Javier Aranda,A. Lafuente Puentedura,J. Caño Velasco,Roberto Contieri,Rodolfo Hurle,Keiichiro Mori,Piotr Radziszewski,Shahrokh F. Shariat,Paolo Gontero,Andrea Necchi,Morgan Rouprêt,Francesco Montorsi,Andrea Salonia,Alberto Briganti,Marco Moschini
出处
期刊:BJUI [Wiley]
标识
DOI:10.1111/bju.16675
摘要

Objective To assess the oncological outcomes of patients with high‐risk (HR) and very high‐risk (VHR) non‐muscle‐invasive bladder cancer (NMIBC) treated with upfront radical cystectomy (RC) vs Bacillus Calmette–Guérin (BCG) instillations from a contemporary European multicentre cohort. Patients and Methods We conducted a retrospective analysis of 1491 patients diagnosed with HR‐ or VHR‐NMIBC from a European multicentre database between 2015 and 2024. Patients were included if they received either upfront RC or at least five doses of BCG. A 1:1 propensity score matching (PSM) according to clinically relevant variables was applied. Progression was defined as muscle‐invasive or metastatic disease. Cumulative incidence plots and multivariable competing risk regression models addressing cancer‐specific mortality (CSM) were fitted. Results Among the 1221 patients with HR‐ ( n = 1221 [90%]) or VHR‐NMIBC ( n = 121 [10%]), 87 (7.1%) underwent upfront RC. The median follow‐up was 2.6 years. After PSM (87 vs 87 patients), the 5‐year CSM rate was similar in patients treated with BCG (13%) vs their upfront RC counterparts (16%) (hazard ratio: 1.77, 95% confidence interval [CI] 0.66–4.73; P = 0.3). Of the 1134 patients who initially received BCG, 73 (6.6%) eventually required delayed RC, with 34 (47%) progressing to muscle‐invasive bladder cancer before delayed RC. The 3‐year CSM rate was comparable in upfront RC (13%) vs delayed RC (11%) among non‐progressing patients ( P = 0.3). However, patients who progressed before delayed RC had worse 3‐year CSM relative to those who did not (13% vs 31%, hazard ratio: 0.32, 95% CI 0.13–0.83; P = 0.018). Conclusion Within a European cohort of patients with HR‐ and VHR‐NMIBC, upfront RC was rarely performed. Patients treated with BCG did not exhibit a CSM disadvantage relative to their upfront RC counterparts. After matching, long‐term CSM was similar between BCG therapy and upfront RC. Delayed RC, led to worse outcomes if performed after progression, but matched upfront RC when performed before progression, underscoring importance of timely surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
大模型应助Faith采纳,获得10
刚刚
2秒前
2秒前
乐瑥发布了新的文献求助10
3秒前
旷意发布了新的文献求助10
3秒前
Owen应助普外科老白采纳,获得10
4秒前
omkg发布了新的文献求助10
6秒前
喜之郎完成签到,获得积分10
6秒前
6秒前
Zee发布了新的文献求助10
7秒前
7秒前
cyxcr发布了新的文献求助10
7秒前
毛豆应助笑点低的凡梦采纳,获得10
7秒前
8秒前
8秒前
lvshihao完成签到,获得积分20
9秒前
ranj发布了新的文献求助10
12秒前
2023AKY完成签到,获得积分10
12秒前
pla发布了新的文献求助10
12秒前
菠萝包发布了新的文献求助10
15秒前
FashionBoy应助踏实的酸奶采纳,获得10
15秒前
李瑞瑞完成签到 ,获得积分10
16秒前
wys完成签到 ,获得积分10
17秒前
17完成签到 ,获得积分10
20秒前
22秒前
23秒前
今后应助乐瑥采纳,获得10
23秒前
杲杲完成签到 ,获得积分10
23秒前
烂漫的冬易完成签到,获得积分10
25秒前
27秒前
苏叶完成签到,获得积分10
28秒前
29秒前
WZQ完成签到,获得积分10
32秒前
苏叶发布了新的文献求助10
32秒前
33秒前
34秒前
勋勋xxx完成签到,获得积分10
36秒前
欣喜寒珊发布了新的文献求助10
39秒前
40秒前
高分求助中
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
Mantodea of the World: Species Catalog Andrew M 500
海南省蛇咬伤流行病学特征与预后影响因素分析 500
Neuromuscular and Electrodiagnostic Medicine Board Review 500
ランス多機能化技術による溶鋼脱ガス処理の高効率化の研究 500
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3464263
求助须知:如何正确求助?哪些是违规求助? 3057568
关于积分的说明 9057665
捐赠科研通 2747637
什么是DOI,文献DOI怎么找? 1507473
科研通“疑难数据库(出版商)”最低求助积分说明 696562
邀请新用户注册赠送积分活动 696083